Shah Gaurav
Reporting owner on Forms 3, 4 and 5, CIK 1725922.
Shah Gaurav reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RCKT · ROCKET PHARMACEUTICALS, INC.CIK 1281895 | officer (CEO) | 2 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RCKT · ROCKET PHARMACEUTICALS, INC.Common Stock | 2026-11-18 | S sold | -2,216 | $2.178 | 1,051,358 | Form 4 |
| RCKT · ROCKET PHARMACEUTICALS, INC.Common Stock, holding | 207,897 | Form 4 | ||||
| RCKT · ROCKET PHARMACEUTICALS, INC.Common Stock, holding | 198,341 | Form 4 | ||||
| RCKT · ROCKET PHARMACEUTICALS, INC.Common Stock | 2026-11-13 | S sold | -3,020 | $2.25 | 1,053,574 | Form 4 |
| RCKT · ROCKET PHARMACEUTICALS, INC.Common Stock, holding | 207,897 | Form 4 | ||||
| RCKT · ROCKET PHARMACEUTICALS, INC.Common Stock, holding | 198,341 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001140361-26-045110 | ROCKET PHARMACEUTICALS, INC. | 2026-11-20 | ||
| Form 4 0001140361-26-044546 | ROCKET PHARMACEUTICALS, INC. | 2026-11-17 |